Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Kathleen M. Dungan MD, MPH Advisory Board

Deborah J. Wexler MD, MSc Associate Editor

See All Experts

featured

Published in Diabetes

Journal Scan / Research · January 23, 2024

Efficacy of Tubeless Automated Insulin Delivery System in Children, Adolescents, and Adults With Type 1 Diabetes

Diabetes Technology & Therapeutics

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Real-World Use of Control-IQ Technology Is Associated With Lower Rates of Severe Hypoglycemia and Diabetic Ketoacidosis

Diabetes Technology & Therapeutics

Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes

Diabetes Technol. Ther. 2024 Jan 01;26(1)11-23, AB Criego, AL Carlson, SA Brown, GP Forlenza, BW Bode, CJ Levy, DW Hansen, IB Hirsch, RM Bergenstal, JL Sherr, SN Mehta, LM Laffel, VN Shah, A Bhargava, RS Weinstock, SA MacLeish, DJ DeSalvo, TC Jones, G Aleppo, BA Buckingham, TT Ly

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Efficacy of Tubeless Automated Insulin Delivery System in Children, Adolescents, and Adults With Type 1 Diabetes

Additional Info

Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes

Further Reading

Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes — 2025

Efficiency of CGM in Predicting Gestational Diabetes and Perinatal Complications

Effect of Sarcopenic Obesity on the Progression of Glycaemic Status in Middle-Aged and Older Adults Without Diabetes

Use of SGLT2 Inhibitors Reduces Epicardial Adipose Tissue More Effectively Compared With GLP-1 Agonists or Exercise in Patients With Type 2 Diabetes and/or Obesity

Prevalence of Metabolic Syndrome Among Children and Adolescents With Obesity

Improving Care and Promoting Health in Populations: Standards of Care in Diabetes — 2025

Perinatal Outcomes in Patients With Early vs Late Gestational Diabetes Mellitus Treated Between 24 and 28 Weeks of Gestation

Association Between Bone Mineral Density and the Risk of Kidney Disease Progression in Patients With Type 1 Diabetes

Role of Intermittent Fasting in Weight Management and Improving Metabolic Health

Consensus Considerations and Good Practice Points for the Use of CGM Systems in Hospital Settings

Weight Changes After Treatment With Semaglutide in Individuals With MASLD/MASH With or Without Type 2 Diabetes

Recently Updated